Department of Urology, Zhejiang University, Zhejiang, People's Republic of China.
Department of Pathology, The First Affiliated Hospital of College of Medicine, Zhejiang University, Zhejiang, People's Republic of China.
Onco Targets Ther. 2014 May 27;7:823-7. doi: 10.2147/OTT.S61524. eCollection 2014.
Renal angiomyolipoma (AML) is recognized as a benign hamartomatous lesion arising in the kidney with no obvious malignant potential. However, epithelioid AML (EAML), a rare variant of AML, is potentially malignant, with aggressive clinical features. It can occur in patients with or without tuberous sclerosis. Because EAML may mimic renal cell carcinoma in imaging studies, differentiation of this tumor from renal cell carcinoma preoperatively is difficult. At times, the lesions may extend into the renal vein and inferior vena cava or metastasize to other organs such as the lung and liver. To clarify the biological nature of EAML, three specific cases that we encountered in clinical practice are analyzed and reported in detail.
肾血管平滑肌脂肪瘤(AML)被认为是一种良性错构瘤性病变,起源于肾脏,无明显恶性潜能。然而,上皮样 AML(EAML)是 AML 的一种罕见变异型,具有潜在的恶性行为,表现出侵袭性的临床特征。它可以发生在有或没有结节性硬化症的患者中。由于 EAML 在影像学研究中可能与肾细胞癌相似,因此术前鉴别该肿瘤与肾细胞癌较为困难。有时,病变可能延伸至肾静脉和下腔静脉,或转移至其他器官,如肺和肝。为了阐明 EAML 的生物学性质,我们详细分析并报告了在临床实践中遇到的三个具体病例。